Delivery Order SPE2DB22D2005-SPE2DB23FJSQ4
- Not listed
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $860 firm fixed price delivery order by the Defense Logistics Agency to supply 100mg/0.5ml auto-injectors of XYOSTED, a testosterone replacement drug. Performance will take place in Conshohocken, Pennsylvania over a one day period from August 30th to August 31st, 2023. The Defense Logistics Agency is the logistics combat support agency of the United States Department of Defense, responsible for...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $754 firm fixed price delivery order by the Defense Logistics Agency to supply 100mg/0.5ml doses of XYOSTED, an auto-injectable testosterone treatment, for delivery to a location in Conshohocken, Pennsylvania from July 21-24, 2023. The Defense Logistics Agency is the logistics combat support agency of the United States Department of Defense, charged with sourcing and provisioning medical...
- Amerisourcebergen Drug Corp has been awarded a five hundred seventy-six dollar firm fixed price delivery order against an unspecified contract vehicle to supply XYOSTED 75 MG/0.5 ML auto-injectors to the Defense Logistics Agency. Performance will occur in Conshohocken, Pennsylvania by the specified completion date of October 23, 2023. No set-aside provisions were applied to this award. The Defense Logistics Agency supports military readiness through the acquisition and distribution of critical...
- The Defense Logistics Agency awarded a $251 firm fixed price delivery order to Amerisourcebergen Drug Corporation for XYOSTED 75 MG/0.5 ML auto-injectors. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the auto-injectable testosterone replacement drug to locations in Conshohocken, Pennsylvania on behalf of the Defense Logistics Agency. Amerisourcebergen Drug Corporation is a division of Amerisourcebergen Corporation, which will perform as the parent company without...
- Amerisourcebergen Drug Corp has been awarded a $1,002.12 firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical contract vehicle to supply 50 MG/0.5 ML auto-injectors of XYOSTED, a medication for testosterone replacement therapy. Performance will occur in Conshohocken, Pennsylvania by October 2023. The Defense Logistics Agency supports military readiness by procuring and providing medical supplies and pharmaceuticals to the Department of Defense. No...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $452.70 firm fixed price delivery order by the Defense Logistics Agency to supply 100mg/0.5ml auto-injectors of XYOSTED, a medication used to treat conditions such as hypogonadism. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period beginning August 1, 2023. No subcontractors or set aside designations were identified. The Defense Logistics...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $533 delivery order by the Defense Logistics Agency to supply 75 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone therapy, for delivery to a location in Conshohocken, Pennsylvania from July 21-24, 2023. The firm fixed price contract was issued utilizing the DLA's Pharmaceutical Prime Vendor program, which centrally manages pharmaceuticals for the Department of Defense and other...
- The Defense Logistics Agency awarded a $306 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561521698 XYOSTED 75 MG/0.5 ML auto-injectors. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the 0.5mL auto-injectable testosterone cypionate product to a location in Conshohocken, Pennsylvania by July 18, 2023 to support Defense Logistics Agency requirements. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation,...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,240 to Amerisourcebergen Drug Corporation for XYOSTED 100 MG/0.5 ML auto-injectors. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the injectable testosterone replacement therapy products to a location in Conshohocken, Pennsylvania by July 10, 2023 to support DLA requirements. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $251 firm fixed price delivery order by the Defense Logistics Agency to supply 100mg/0.5ml auto-injectors of XYOSTED, a medication used to treat conditions such as hypogonadism. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a two day period concluding on August 29, 2023. No subcontractors or set aside designations were identified. The Defense Logistics...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB23FJSQ4Delivery Order
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $251,420 delivery order by the Defense Logistics Agency to supply XYOSTED 75 MG/0.5 ML auto-injectors. Performance will take place in Conshohocken, Pennsylvania under firm fixed pricing over a period of four days from August 4th through the 7th of 2023. The Defense Logistics Agency is the logistics combat support agency of the United States Department of Defense, charged with sourcing and provisioning medical materiel to support military treatment facilities. This delivery order was issued against an existing DLA pharmaceuticals contract vehicle to meet immediate demand for testosterone replacement therapy drugs. No subcontractors or set-aside designations were identified in the award information.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $251 | 8/4/23 |